Compugen reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
aTyr Pharma USD 1.72M 10.79M Mar/2026
Bio Path USD 0 0 Mar/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
Immunic USD 0 0 Jun/2024
Minerva Neurosciences USD 0 86.58M Sep/2024
RedHill Biopharma USD 900K 710K Dec/2025
TherapeuticsMD USD 0 0 Mar/2022